7 Results for "

SP94

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "SP94" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P11050
CAS No.: 1309883-67-7
Target:  

Peptides

Research Areas:  

Cancer

SP94 peptide, Cys conjugated is a hepatocellular carcinoma (HCC)-targeting peptide conjugated with Cys. SP94 peptide, Cys conjugated can be used for synthesis of stimuli-responsive peptide nanomaterials (SRPNs) like platinum nanocluster assemblies (PT-NA) and it promotes the entry of PT-NA into HCC cells by mediating endocytosis. SP94 peptide, Cys conjugated can be used for cancers research .
loading...
    loading...
Cat. No.: HY-P11050A
CAS No.: 1158983-49-3
Target:  

Apoptosis

Research Areas:  

Cancer

SP94 is a peptide ligand with high specificity for hepatocellular carcinoma cells. SP94 selectively binds to multiple hepatocellular carcinoma cell lines in vitro. SP94 inhibits tumor growth in a mouse model of hepatocellular carcinoma by promoting apoptosis and reducing angiogenesis. SP94 can be used as a specific probe for hepatocellular carcinoma imaging. SP94 is useful for hepatocellular carcinoma research .
loading...
    loading...
Cat. No.: HY-172500
DSPE-PEG2000-Mal-CLPLIPTHIISFS is a PEG compound composed of DSPE and the liver cancer targeting peptide SP94 (HY-P11050A) (sequence SFSIIHTPILPL). SP94 exhibits specific binding to hepatocellular carcinoma (HCC) cells. DSPE-PEG2000-Mal-CLPLIPTHIISFS can be used to prepare lipid nanoparticles to form liver cancer-targeting nanocarriers.
loading...
    loading...
Cat. No.: HY-187491A
Synonyms: DOPE-PEG2000-Mal-Cys-SP94
DOPE-PEG2000-SP94 (DOPE-PEG2000-Mal-Cys-SP94) is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the SP94 peptide (sequence: SFSIIHTPILPL), a hepatocellular carcinoma (HCC) -targeting peptide. DOPE-PEG2000-SP94 is used for HCC-targeted drug delivery through liposome and nanoparticle functionalization.
loading...
    loading...
Cat. No.: HY-172500A
DSPE-PEG3400-Mal-CLPLIPTHIISFS is a PEG compound composed of DSPE and the liver cancer targeting peptide SP94 (HY-P11050A) (sequence SFSIIHTPILPL). SP94 exhibits specific binding to hepatocellular carcinoma (HCC) cells. DSPE-PEG3400-Mal-CLPLIPTHIISFS can be used to prepare lipid nanoparticles to form liver cancer-targeting nanocarriers.
loading...
    loading...
Cat. No.: HY-172499
DSPE-PEG1000-Mal-CLPLIPTHIISFS is a PEG compound composed of DSPE and the liver cancer targeting peptide SP94 (HY-P11050A) (sequence SFSIIHTPILPL). SP94 exhibits specific binding to hepatocellular carcinoma (HCC) cells. DSPE-PEG1000-Mal-CLPLIPTHIISFS can be used to prepare lipid nanoparticles to form liver cancer-targeting nanocarriers.
loading...
    loading...
Cat. No.: HY-172501
DSPE-PEG5000-Mal-CLPLIPTHIISFS is a PEG compound composed of DSPE and the liver cancer targeting peptide SP94 (HY-P11050A) (sequence SFSIIHTPILPL). SP94 exhibits specific binding to hepatocellular carcinoma (HCC) cells. DSPE-PEG5000-Mal-CLPLIPTHIISFS can be used to prepare lipid nanoparticles to form liver cancer-targeting nanocarriers.
loading...
    loading...